Efficacy of Changing to TRAVATAN® From Prior Therapy
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the efficacy and tolerability of TRAVATAN® solution
without BAK (benzalkonium chloride) after changing from prior latanoprost 0.005% ophthalmic
solution monotherapy in subjects with open-angle glaucoma or ocular hypertension due to
tolerability issues.